New Biotechnology Companies

Commercialization Strategies of Biotechnology Companies

In the biotechnology industry today, there are many business models for project commercialization. These models range from independent vertical integration to certain forms of collaboration with pharmaceutical companies to complete acquisitions of projects by the big pharmaceutical companies. In this thesis, we wanted to study commercialization strategies of several biotechnology companies. We ...

Financing Development Stage Biotechnology Companies: RMs vs

We examine reverse mergers (RMs) in the biotechnology industry and find that, when compared to initial public offerings (IPOs), RMs are smaller, have significantly lower market valuations relative to size, and generally invest less. We also find that RMs exhibit positive abnormal returns on the announcement date and throughout the first year after the RM event. In looking at liquidity measures,...

prioritizing development and success challenges of biotechnology spin off companies

one of the main solutions to commercialize intellectual assets of universities and research centers is developing spin off companies. the main objective of this article is identification and prioritization of the challenges which these firms confront with to become successful. to address the objective, we used exploratory mixed method. after investigating the related literature, we made eleven ...

New Trends in Nucleoside Biotechnology

This review focuses on new trends in nucleoside biotechnology, which have emerged during the last decade. Continuously growing interest in the study of this class of compounds is fueled by a number of factors: ( i ) a growing need for large-scale production of natural 2 ' -deoxy- β -D-ribonucleosides as well as their analogs with modifications in the carbohydrate and base fragments, which can...

A New Branch of Biotechnology